14 April 2022 - Regeneron continues to progress its next generation antibodies, and has initiated a first in human trial. ...
11 April 2022 - Drug makers on Monday pledged to speed up the market launch of new drugs in underserved ...
6 April 2022 - The U.S. FDA said it is aiming to come up with a decision on coronavirus strain ...
4 April 2022 - New PDUFA goal date scheduled for 14 July 2022. ...
1 April 2022 - - Merck today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug ...
25 March 2022 - Bristol Myers Squibb today announced that the U.S. FDA has extended the review of the supplemental ...
21 March 2022 - FDA Sets Goal Date of August 17, 2022. ...
14 March 2022 - Incyte announced today that the U.S. FDA has extended the review period for the supplemental new ...
9 March 2022 - The FDA plans to hold an advisory committee meeting. ...
4 March 2022 - Australian patients will have improved access to clinical trials due to reforms to be introduced by ...
3 March 2022 - FDA sets updated PDUFA goal date of June 25, 2022. ...
28 February 2022 - AbbVie today announced that the U.S. FDA has extended its review period for Skyrizi (risankizumab-rzaa) for ...
24 February 2022 - MannKind Corporation was informed that the U.S. FDA issued an information request to United Therapeutics Corporation ...
24 February 2022 - Major amendment to Tyvaso DPI new drug application pushes FDA decision date to May 2022. ...
24 February 2022 - FDA sets updated PDUFA goal date of 16 June 2022. ...